Insider: Musket David B Director - CAPRICOR THERAPEUTICS, INC.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 31,536 | 70,962 | 102,498 |
| Value | $1,012,620.96 | $2,278,589.82 | $3,291,210.78 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 10/12/2023 | AAP | 410 | Direct | COM | $2.75 | $1,127.50 | 31,536 |
| 10/09/2023 | AAP | 5,083 | Direct | COM | $2.82 | $14,334.06 | 31,126 |
| 10/04/2023 | AAP | 2,500 | Direct | COM | $2.90 | $7,250.00 | 26,043 |
| 06/27/2022 | DDS | 17,775 | Direct | COM | $4.44 | $78,921.00 | 40,962 |
| 05/09/2017 | AAP | 25,000 | Direct | COM | $3.10 | $77,500.00 | 25,000 |
| 01/21/2015 | AAP | 70,962 | Indirect | COM | $3.52 | $249,999.13 | 70,962 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research